CVS HEALTH Corp (CVS) Financials
Annual revenue, profitability and per-share results for CVS HEALTH Corp, as reported in SEC filings.
Revenue • FY2025
$402.07B
▲ 7.8%YoY
Net income • FY2025
$1.77B
▼ 61.7%YoY
Gross margin • FY2025
45.0%
Diluted EPS • FY2025
$1.39
▼ 62.0%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $402.07B | $1.77B | $180.9B | $1.39 | $7.81B | 1.2% | +7.8% |
| FY2024 | $372.81B | $4.61B | $166.52B | $3.66 | $6.33B | 2.3% | +4.2% |
| FY2023 | $357.78B | $8.34B | $140.68B | $6.47 | $10.39B | 3.8% | +10.9% |
| FY2022 | $322.47B | $4.15B | $125.58B | $3.14 | $13.45B | 2.4% | +10.4% |
Figures as reported in CVS HEALTH Corp's 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Financials for companies related to CVS
Never miss a CVS filing.
Get an email when CVS files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.